ArticleNEJM AI2026
The Inverse Care Law in the Age of AI - Geographic Disparities in Health Care Technology Access.
Article in NEJM AI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
More than 50 years after Hart proposed the inverse care law, artificial intelligence (AI) in health care risks repeating the same pattern: Those who could benefit most have the least access. Using publicly available U.S. data, we show that rural areas face greater health burdens but have fewer health care resources and lower capacity to implement AI solutions. These disparities most likely extend beyond the United States. Age-adjusted mortality rates, chronic disease prevalence, and socioeconomic challenges increase with rurality, while the health care workforce and infrastructure decline. This mismatch creates contexts where AI could be most beneficial. However, AI implementation capacity declines from metropolitan to rural areas across key indicators, including interoperability infrastructure, AI adoption, and large language model readiness. In addition, clinical AI systems trained predominantly on urban populations raise concerns about distribution shift and transportability when applied to rural populations. Without deliberate intervention, AI risks amplifying rather than addressing existing disparities. Addressing this misalignment requires coordinated policy, research, and regulatory efforts that explicitly account for geography and equity. Policy should support foundational infrastructure in underserved systems, research should evaluate AI against current care alternatives rather than ideal standards, and regulation should address disparities in access and diffusion to ensure AI benefits reach areas of greatest clinical need.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.